OBB Newsletter

  • Enter your e-mail address below to subscribe to the Orange Book Blog newsletter. If a new post is added during the day, you'll receive it by e-mail the next morning.

Enter your email address:

Delivered by FeedBurner

AddThis Feed Button

Disclaimer

  • Orange Book Blog is published for informational purposes only; it contains no legal advice whatsoever. Publication of Orange Book Blog does not create an attorney-client relationship. Orange Book Blog is Aaron Barkoff's personal website and it is intended primarily for other attorneys. Orange Book Blog is not edited by McDonnell Boehnen Hulbert & Berghoff LLP ("MBHB") or its clients. Therefore, no part of Orange Book Blog--whether information, commentary, or other--may be attributed to MBHB or its clients. Readers should be aware that MBHB represents many companies in the pharmaceutical and biotechnology industries, and therefore Orange Book Blog may occasionally report on news that relates to MBHB clients. Orange Book Blog will always strive to be unbiased in its reporting. All information on Orange Book Blog should be double-checked for its accuracy and current applicability. -- © Aaron F. Barkoff 2006-08

« OBB News Briefs | Main | GPhA Files Amicus Brief in Appeal of "Baseless Paragraph IV Certification" Case; Warns of Chilling Effect on Future Patent Challenges »

May 07, 2008

ACI "FDA Boot Camp" Conference, San Francisco, May 29-30

American Conference Institute's very popular "FDA Boot Camp" returns to San Francisco later this month, May 29-30.

The conference is designed to give patent lawyers, product liability lawyers, and life sciences investment and securities experts a strong working knowledge of core FDA regulatory competencies.  The conference features FDA regulatory and patent law experts from pharmaceutical companies and outside law firms.

Presentations on the agenda include:

  • The Basics: Understanding and Working with the FDA -- Jurisdiction, Functions, Organization, and Operations
  • The Nature of the Approval Process
  • Patent and IP Overview: Hatch-Waxman, Trademark Protection, and More
  • From Theory to Practice: FDAAA, Future FDA and Legislative Priorities, Other Enforcement Initiatives, and Beyond
  • Non-Patent Exclusivity
  • Bioequivalence: What Lawyers Need to Know
  • Follow-On (Comparable or Biosimilar) Biologics

For more information or to register, please visit the conference website.

Comments

Post a comment

Comments are moderated, and will not appear on this weblog until the author has approved them.